Richard William Scalzo, Chief Financial Officer at CRESCENT BIOPHARMA, INC. (CBIO), sold 568 shares at $17.90 ($10K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($10k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |
| DYN | SELL | 2024-12-11 | $41K | — | Filing → |